Home › Funds › CLARK ESTATES INC/NY › GEHC
CLARK ESTATES INC/NY position in GEHC
GE HEALTHCARE TECHNOLOGIES I · Health Care
CLARK ESTATES INC/NY reported holding 265,000 shares of GEHC (GE HEALTHCARE TECHNOLOGIES I) in its Q3 2026 13F filing — a position valued at US$17.3M, representing 4.03% of its reported portfolio and ranking #6 among its reported holdings. CLARK ESTATES INC/NY has disclosed GEHC holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CLARK ESTATES INC/NY's GEHC position evolved
CLARK ESTATES INC/NY first disclosed a stake in GEHC in Q3 2023 at 325,000 shares (US$22.1M). The position peaked in Q4 2023 at 325,000 shares, worth US$25.1M. Across 8 filings, CLARK ESTATES INC/NY increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 265,000 shares valued at US$17.3M. Notable position changes include a 31% trim in Q1 2024 (shares fell 14% over the following quarter), a 40% trim in Q3 2024 (shares fell 16% over the following quarter), a 74% trim in Q1 2025 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 325.00K | $22.11M | New |
| Q4 2023 | 325.00K | $25.13M | Hold |
| Q1 2024 | 225.00K | $20.45M | Reduce |
| Q2 2024 | 190.12K | $14.81M | Reduce |
| Q3 2024 | 115.00K | $10.79M | Reduce |
| Q4 2024 | 115.00K | $8.99M | Hold |
| Q1 2025 | 30.00K | $2.42M | Reduce |
| Q3 2026 | 265.00K | $17.32M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GEHC and 13F data
GEHC (GE HEALTHCARE TECHNOLOGIES I) is a Health Care company. 27 other funds we track also report a position in GEHC — the largest reported positions include Dodge & Cox (US$2.42B), DODGE & COX (US$2.42B), Harris Associates (Oakmark) (US$981.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GEHC
- Dodge & Cox 37.86M sh · $2.42B · Q2 2026
- DODGE & COX 37.86M sh · $2.42B · Q2 2026
- Harris Associates (Oakmark) 15.33M sh · $981.25M · Q2 2026
- HARRIS ASSOCIATES L P 15.33M sh · $981.25M · Q2 2026
- BARROW HANLEY MEWHINNEY & STRAUSS LLC 13.77M sh · $900.14M · Q3 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 12.25M sh · $784.15M · Q2 2026
- TRIAN FUND MANAGEMENT, L.P. 3.09M sh · $197.49M · Q2 2026
More on CLARK ESTATES INC/NY
FAQ
How long has CLARK ESTATES INC/NY held GEHC?
CLARK ESTATES INC/NY has disclosed GEHC holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
What is CLARK ESTATES INC/NY's current position in GEHC?
As of Q3 2026, CLARK ESTATES INC/NY holds 265.00K shares of GEHC (GE HEALTHCARE TECHNOLOGIES I), valued at $17.32M, representing 4.03% of its reported portfolio and ranking #6.
Has CLARK ESTATES INC/NY been buying or selling GEHC?
In the latest 13F filing (Q3 2026), CLARK ESTATES INC/NY newly opened its position in GEHC. The position peaked in Q4 2023 at 325.00K shares.
Which other funds hold GEHC?
Other major institutional holders of GEHC include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.